Platelet activation is associated with myocardial infarction in patients with pneumonia

Journal of the American College of Cardiology

Volumn 64, Issue 18, 2014, Pages 1917-1925

  Cangemi, Roberto ^a   Casciaro, Marco ^a   Rossi, Elisabetta ^a   Calvieri, Camilla ^a   Bucci, Tommaso ^a   Calabrese, Cinzia Myriam ^a   Taliani, Gloria ^a   Falcone, Marco ^b   Palange, Paolo ^b   Bertazzoni, Giuliano ^a   Farcomeni, Alessio ^b   Grieco, Stefania ^a   Pignatelli, Pasquale ^a   Violi, Francesco ^a   Albanese, Fabiana ^c   Biliotti, Elisa ^c   Carnevale, Roberto ^c   Catasca, Elisa ^c   Celestini, Andrea ^c   Esvan, Rozenn ^c   Fazi, Lucia ^c   Marinelli, Paolo ^c   Mordenti, Michela ^c   Napoleone, Laura ^c   Palumbo, Michela ^c   Pastori, Daniele ^c   Perri, Ludovica ^c   Proietti, Marco ^c   Marco, Rivano Capparuccia ^c   Russo, Alessandro ^c   Russo, Roberta ^c   Sarallo, Valentino ^c   Salvatori, Gabriele ^c   Scarpellini, Maria Gabriella ^c   Ullo, Ines ^c   more..

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c NONE

Author keywords

cardiovascular disease; human; platelet aggregation; prospective studies; risk factors

Indexed keywords

ACETYLSALICYLIC ACID; CD40 LIGAND; PADGEM PROTEIN; THROMBOXANE B2; TROPONIN T; ANTITHROMBOCYTIC AGENT; BIOLOGICAL MARKER;

ADULT; AGED; BLOOD LEVEL; COMMUNITY ACQUIRED PNEUMONIA; DISEASE ASSOCIATION; FEMALE; HEART EJECTION FRACTION; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PNEUMONIA SEVERITY INDEX; REVIEW; RISK FACTOR; THROMBOCYTE ACTIVATION; THROMBOCYTE VOLUME; BLOOD; CLINICAL TRIAL; COMMUNITY ACQUIRED INFECTION; COMPLICATION; ELECTROCARDIOGRAPHY; FOLLOW UP; MIDDLE AGED; MYOCARDIAL INFARCTION; PHYSIOLOGY; PNEUMONIA; PROGNOSIS; PROSPECTIVE STUDY;

AGED; ASPIRIN; BIOLOGICAL MARKERS; CD40 LIGAND; COMMUNITY-ACQUIRED INFECTIONS; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; P-SELECTIN; PLATELET ACTIVATION; PLATELET AGGREGATION INHIBITORS; PNEUMONIA; PROGNOSIS; PROSPECTIVE STUDIES; THROMBOXANE B2; TROPONIN T;

EID: 84908377319     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2014.07.985     Document Type: Article

References (37)

1. C. McCabe, C. Kirchner, and H. Zhang Guideline-concordant therapy and reduced mortality and length of stay in adults with community-acquired pneumonia: playing by the rules Arch Intern Med 169 2009 1525 1531
2. V.F. Corrales-Medina, D.M. Musher, and S. Shachkina Acute pneumonia and the cardiovascular system Lancet 381 2013 496 505
3. K.L. Nichol, J. Nordin, and J. Mullooly Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly N Engl J Med 348 2003 1322 1332
4. V.F. Corrales-Medina, D.M. Musher, and G.A. Wells Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality Circulation 125 2012 773 781
5. C.L. Chang, G.D. Mills, and N.C. Karalus Biomarkers of cardiac dysfunction and mortality from community-acquired pneumonia in adults PLoS One 8 2013 e62612
6. G.A. FitzGerald Mechanisms of platelet activation: thromboxane A2 as an amplifying signal for other agonists Am J Cardiol 68 Suppl 1991 11B 15B
7. Antithrombotic Trialists' Collaboration Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients BMJ 324 2002 71 86
8. F. Angelico, C. Alessandri, and D. Ferro Enhanced soluble CD40L in patients with the metabolic syndrome: relationship with in vivo thrombin generation Diabetologia 49 2006 1169 1174
9. A.D. Blann, S.K. Nadar, and G.Y. Lip The adhesion molecule P-selectin and cardiovascular disease Eur Heart J 24 2003 2166 2179
10. P. Patrignani, P. Filabozzi, and C. Patrono Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects J Clin Invest 69 1982 1366 1372
11. M.L. Capone, S. Tacconelli, and M.G. Sciulli Clinical pharmacology of platelet, monocyte, and vascular cyclooxygenase inhibition by naproxen and low-dose aspirin in healthy subjects Circulation 109 2004 1468 1471
12. R. De Caterina, D. Giannessi, and W. Bernini Low-dose aspirin in patients recovering from myocardial infarction. Evidence for a selective inhibition of thromboxane-related platelet function Eur Heart J 6 1985 409 417
13. M. Venditti, M. Falcone, S. Corrao Study Group of the Italian Society of Internal Medicine Outcomes of patients hospitalized with community-acquired, health care-associated, and hospital-acquired pneumonia Ann Intern Med 150 2009 19 26
14. D. Aujesky, and M.J. Fine The pneumonia severity index: a decade after the initial derivation and validation Clin Infect Dis 47 suppl 2008 S133 S139
15. J. Perk, G. De Backer, H. Gohlke European Association for Cardiovascular Prevention & Rehabilitation (EACPR); ESC Committee for Practice Guidelines (CPG) European guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) Eur Heart J 33 2012 1635 1701
16. L. Loffredo, A. Marcoccia, and P. Pignatelli Oxidative-stress-mediated arterial dysfunction in patients with peripheral arterial disease Eur Heart J 28 2007 608 612
17. K.F. Rabe, S. Hurd, A. Anzueto Global Initiative for Chronic Obstructive Lung Disease Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary Am J Respir Crit Care Med 176 2007 532 555
18. K. Thygesen, J.S. Alpert, and A.S. Jaffe Third universal definition of myocardial infarction J Am Coll Cardiol 60 2012 1581 1598
19. T. Reichlin, W. Hochholzer, and S. Bassetti Early diagnosis of myocardial infarction with sensitive cardiac troponin assays N Engl J Med 361 2009 858 867
20. D. Viasus, C. Garcia-Vidal, and F. Manresa Risk stratification and prognosis of acute cardiac events in hospitalized adults with community-acquired pneumonia J Infect 66 2013 27 33
21. J. Ramirez, S. Aliberti, and M. Mirsaeidi Acute myocardial infarction in hospitalized patients with community-acquired pneumonia Clin Infect Dis 47 2008 182 187
22. D.M. Musher, A.M. Rueda, and A.S. Kaka The association between pneumococcal pneumonia and acute cardiac events Clin Infect Dis 45 2007 158 165
23. V.F. Corrales-Medina, J. Serpa, and A.M. Rueda Acute bacterial pneumonia is associated with the occurrence of acute coronary syndromes Medicine (Baltimore) 88 2009 154 159
24. P. Mandal, J.D. Chalmers, and G. Choudhury Vascular complications are associated with poor outcome in community-acquired pneumonia QJM 104 2011 489 495
25. P. Pignatelli, S. Di Santo, and F. Barilla Multiple anti-atherosclerotic treatments impair aspirin compliance: effects on aspirin resistance J Thromb Haemost 6 2008 1832 1834
26. A.L. Frelinger III, M.I. Furman, and M.D. Linden Residual arachidonic acid-induced platelet activation via an adenosine diphosphate-dependent but cyclooxygenase-1- and cyclooxygenase-2-independent pathway: a 700-patient study of aspirin resistance Circulation 113 2006 2888 2896
27. A. Modica, F. Karlsson, and T. Mooe Platelet aggregation and aspirin non-responsiveness increase when an acute coronary syndrome is complicated by an infection J Thromb Haemost 5 2007 507 511
28. J.R. Fitzgerald, T.J. Foster, and D. Cox The interaction of bacterial pathogens with platelets Nat Rev Microbiol 4 2006 445 457
29. R.P. Kreutz, K.P. Bliden, and U.S. Tantry Viral respiratory tract infections increase platelet reactivity and activation: an explanation for the higher rates of myocardial infarction and stroke during viral illness J Thromb Haemost 3 2005 2108 2109
30. M. Mirsaeidi, P. Peyrani, and S. Aliberti Thrombocytopenia and thrombocytosis at time of hospitalization predict mortality in patients with community-acquired pneumonia Chest 137 2010 416 420
31. J.F. Martin, S.D. Kristensen, and A. Mathur The causal role of megakaryocyte-platelet hyperactivity in acute coronary syndromes Nat Rev Cardiol 9 2012 658 670
32. J. Berthet, P. Damien, and H. Hamzeh-Cognasse Human platelets can discriminate between various bacterial LPS isoforms via TLR4 signaling and differential cytokine secretion Clin Immunol 145 2012 189 200
33. R.J. Stark, N. Aghakasiri, and R.E. Rumbaut Platelet-derived Toll-like receptor 4 (Tlr-4) is sufficient to promote microvascular thrombosis in endotoxemia PLoS One 7 2012 e41254
34. J.A. de Lemos Increasingly sensitive assays for cardiac troponins: a review JAMA 309 2013 2262 2269
35. J.T. Saunders, V. Nambi, and J.A. de Lemos Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study Circulation 123 2011 1367 1376
36. D. Capodanno, A. Patel, and K. Dharmashankar Pharmacodynamic effects of different aspirin dosing regimens in type 2 diabetes mellitus patients with coronary artery disease Circ Cardiovasc Interv 4 2011 180 187
37. T. Grosser, S. Fries, and J.A. Lawson Drug resistance and pseudoresistance: an unintended consequence of enteric coating aspirin Circulation 127 2013 377 385